4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001994972-25-000003
Chief Medical Officer sold 3,382 shares at an average $8.94 ($30,242)
- Chief Medical Officer acquired 9,570 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Adler Eric · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-15 | Grant or award : show line 1 in the form | +9,570 | 76,643 | D | ||
| 2025-10-17 | Sale : show line 2 in the form | −3,344 | $8.94 | $29,879 | 73,299 | D |
| 2025-10-17 | Sale : show line 3 in the form | −38 | $9.56 | $363 | 73,261 | D |
| Open-market sales · 3,382 sh · avg $8.94 · $30,242 | ||||||
Loading xslF345X05/form4-10172025_111047.xml…